These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 35151296)
1. Preparing newborn screening for the future: a collaborative stakeholder engagement exploring challenges and opportunities to modernizing the newborn screening system. Andrews SM; Porter KA; Bailey DB; Peay HL BMC Pediatr; 2022 Feb; 22(1):90. PubMed ID: 35151296 [TBL] [Abstract][Full Text] [Related]
2. Expert Evaluation of Strategies to Modernize Newborn Screening in the United States. Bailey DB; Porter KA; Andrews SM; Raspa M; Gwaltney AY; Peay HL JAMA Netw Open; 2021 Dec; 4(12):e2140998. PubMed ID: 34964853 [TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
4. Charting the Ethical Frontier in Newborn Screening Research: Insights from the NBSTRN ELSI Researcher Needs Survey. Unnikumaran Y; Lietsch M; Brower A Int J Neonatal Screen; 2024 Sep; 10(3):. PubMed ID: 39311366 [TBL] [Abstract][Full Text] [Related]
5. Systems Integration: The Next Frontier in Newborn-Screening Timeliness. Simon NJ; Atkins A; Yusuf C; Tarini BA J Public Health Manag Pract; 2020; 26(6):E8-E15. PubMed ID: 30789598 [TBL] [Abstract][Full Text] [Related]
6. Including ELSI research questions in newborn screening pilot studies. Goldenberg AJ; Lloyd-Puryear M; Brosco JP; Therrell B; Bush L; Berry S; Brower A; Bonhomme N; Bowdish B; Chrysler D; Clarke A; Crawford T; Goldman E; Hiner S; Howell RR; Orren D; Wilfond BS; Watson M; Genet Med; 2019 Mar; 21(3):525-533. PubMed ID: 30100612 [TBL] [Abstract][Full Text] [Related]
7. A Window of Opportunity for Newborn Screening. Bailey DB Mol Diagn Ther; 2022 May; 26(3):253-261. PubMed ID: 35507129 [TBL] [Abstract][Full Text] [Related]
8. Provision of information about newborn screening antenatally: a sequential exploratory mixed-methods project. Ulph F; Wright S; Dharni N; Payne K; Bennett R; Roberts S; Walshe K; Lavender T Health Technol Assess; 2017 Oct; 21(55):1-240. PubMed ID: 28967862 [TBL] [Abstract][Full Text] [Related]
9. The ethical challenges and opportunities of implementing engagement strategies in health research. Salerno J; Coleman KJ; Jones F; Peters ES Ann Epidemiol; 2021 Jul; 59():37-43. PubMed ID: 33894383 [TBL] [Abstract][Full Text] [Related]
10. Healthcare stakeholders' perceptions and experiences of factors affecting the implementation of critical care telemedicine (CCT): qualitative evidence synthesis. Xyrichis A; Iliopoulou K; Mackintosh NJ; Bench S; Terblanche M; Philippou J; Sandall J Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012876. PubMed ID: 33599282 [TBL] [Abstract][Full Text] [Related]
11. Mandatory newborn screening in the United States: History, current status, and existential challenges. McCandless SE; Wright EJ Birth Defects Res; 2020 Mar; 112(4):350-366. PubMed ID: 32115905 [TBL] [Abstract][Full Text] [Related]
12. Development of newborn screening connect (NBS connect): a self-reported patient registry and its role in improvement of care for patients with inherited metabolic disorders. Osara Y; Coakley K; Devarajan A; Singh RH Orphanet J Rare Dis; 2017 Jul; 12(1):132. PubMed ID: 28724394 [TBL] [Abstract][Full Text] [Related]
13. Attitudes and beliefs of pediatricians and genetic counselors regarding testing and screening for CF and G6PD: implications for policy. Koopmans J; Hiraki S; Ross LF Am J Med Genet A; 2006 Nov; 140(21):2305-11. PubMed ID: 17022079 [TBL] [Abstract][Full Text] [Related]
14. Regulatory scripting: Stakeholder participation in food and drug administration medical device advisory meetings. White SK; Leiter V; Le MH; Helms CK PLoS One; 2023; 18(2):e0281774. PubMed ID: 36795788 [TBL] [Abstract][Full Text] [Related]
15. Early Check: translational science at the intersection of public health and newborn screening. Bailey DB; Gehtland LM; Lewis MA; Peay H; Raspa M; Shone SM; Taylor JL; Wheeler AC; Cotten M; King NMP; Powell CM; Biesecker B; Bishop CE; Boyea BL; Duparc M; Harper BA; Kemper AR; Lee SN; Moultrie R; Okoniewski KC; Paquin RS; Pettit D; Porter KA; Zimmerman SJ BMC Pediatr; 2019 Jul; 19(1):238. PubMed ID: 31315600 [TBL] [Abstract][Full Text] [Related]
16. Expanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective. van Dijk T; Kater A; Jansen M; Dondorp WJ; Blom M; Kemp S; Langeveld M; Cornel MC; van der Pal SM; Henneman L Front Pediatr; 2021; 9():706394. PubMed ID: 34692604 [TBL] [Abstract][Full Text] [Related]
17. Understanding newborn screening system issues with emphasis on cystic fibrosis screening. Therrell BL; Lloyd-Puryear MA; Mann MY J Pediatr; 2005 Sep; 147(3 Suppl):S6-10. PubMed ID: 16202785 [TBL] [Abstract][Full Text] [Related]
18. Concerns of newborn blood screening advisory committee members regarding storage and use of residual newborn screening blood spots. Rothwell EW; Anderson RA; Burbank MJ; Goldenberg AJ; Lewis MH; Stark LA; Wong B; Botkin JR Am J Public Health; 2011 Nov; 101(11):2111-6. PubMed ID: 21330580 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up data collection and use in state newborn screening programs. Hoff T; Ayoob M; Therrell BL Arch Pediatr Adolesc Med; 2007 Oct; 161(10):994-1000. PubMed ID: 17909144 [TBL] [Abstract][Full Text] [Related]